Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000004971 | SCV000194518 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2013-03-05 | criteria provided, single submitter | clinical testing | |
Pathology and Clinical Laboratory Medicine, |
RCV000004971 | SCV001438861 | likely pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | criteria provided, single submitter | clinical testing | ||
Baylor Genetics | RCV000004971 | SCV001523583 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2020-02-12 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001851658 | SCV002131826 | pathogenic | not provided | 2024-03-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1923*) in the PCNT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCNT are known to be pathogenic (PMID: 18174396, 22821869). This variant is present in population databases (rs119479062, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with PCNT-related conditions (PMID: 18174396, 30214071). ClinVar contains an entry for this variant (Variation ID: 4706). For these reasons, this variant has been classified as Pathogenic. |
Genomic Medicine Center of Excellence, |
RCV000004971 | SCV005374392 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2024-09-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000004971 | SCV000025147 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2008-02-08 | no assertion criteria provided | literature only |